| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/15/2008 | WO2008055951A1 Method for mixing powders |
| 05/15/2008 | WO2008055871A1 Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| 05/15/2008 | WO2008055363A1 Herbal product comprising cinnamon, bitter melon and omega-3 fatty acids |
| 05/15/2008 | WO2008034866A3 Dbait and uses thereof |
| 05/15/2008 | WO2008030567A3 Dry powder compound formulations and uses thereof |
| 05/15/2008 | WO2008022032A3 Topical pharmaceutical compositions comprising calcium-channel blocker and method of using same |
| 05/15/2008 | WO2008015695A3 Inclusion complex of olopatadine and cyclodextrin |
| 05/15/2008 | WO2008013735A8 Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
| 05/15/2008 | WO2008012542A3 Polysaccharide derivatives of erythropoietin |
| 05/15/2008 | WO2007147372B1 Pharmaceutical composition for administration by injection |
| 05/15/2008 | WO2007133508A8 Water dispersible films for delivery of active agents to the epidermis |
| 05/15/2008 | WO2007124082A3 Buffering agents for biopharmaceutical formulations |
| 05/15/2008 | WO2007110003A3 Micellar carriers for drugs with anti-cancer activity |
| 05/15/2008 | WO2007107787A3 Liquid and solid dosage formulations containing date fruit (phoenix dactylifera) |
| 05/15/2008 | WO2007106544A3 Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 05/15/2008 | WO2007084916A3 Thimerosal removal device |
| 05/15/2008 | WO2007084765A3 Injectable combination therapy for eye disorders |
| 05/15/2008 | US20080114458 Intervertebral disc treatment devices and methods |
| 05/15/2008 | US20080114285 Energy-activated targeted cancer therapy |
| 05/15/2008 | US20080114155 Modified Human Interferon Polypeptides and Their Uses |
| 05/15/2008 | US20080114154 Protease resistance |
| 05/15/2008 | US20080114080 Screening agents which act synergistically to compensate for defective chloride ion transport in cells harboring mutation in CFTR; G-protein coupled receptor modulation |
| 05/15/2008 | US20080114079 TRPM2-specfic inhibitors |
| 05/15/2008 | US20080114078 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 05/15/2008 | US20080114077 Symmetrically Branched Polymer Conjugates and Microarray Assays |
| 05/15/2008 | US20080114076 Biodegradable polyester; kits with syringes |
| 05/15/2008 | US20080114069 Methods of inducing terminal differentiation |
| 05/15/2008 | US20080114057 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 05/15/2008 | US20080113916 Povidone-Containing Carriers for Polypeptide Growth Factors |
| 05/15/2008 | US20080113905 Biologically active peptide with extended half-life and a slower clearance compared to unPEGylated peptide; PEGylated GLP-1 compounds treat diabetes, obesity, irritable bowel syndrome |
| 05/15/2008 | US20080113868 Bis-(N,N disubstituted-aminophenyl)phenyl methane nonstaining, fugitive colorants that decolorize rapidly when applied to surfaces having a basic pH, such as concrete, but are visually apparent on vegetation and soil; use applying agricultural chemicals, paints, as spray pattern indicators in landscaping |
| 05/15/2008 | US20080113865 Gleditsia amorphoides seedless pod extract and its use as an agricultural adjuvant |
| 05/15/2008 | US20080113436 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
| 05/15/2008 | US20080113343 Method of Inhibiting Prostate Cancer Cell Proliferation |
| 05/15/2008 | US20080113037 Topical Compositions Comprising Polyhydroxy Acids and/or Lactones for Improved Cutaneous Effects of Oxidative Therapeutic Drugs |
| 05/15/2008 | US20080113035 medical equipment, drug delivery devices or implants containing antimitotic agents such as taxol or diterpenes, used for treating inflammatory diseases such as psoriasis or multiple sclerosis |
| 05/15/2008 | US20080113027 Water insoluble polymer matrix for drug delivery |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080113022 non-film-coated tablets comprising a mixture of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride, microcrystalline cellulose, lubricants, colloidal silica and lactose, having stability |
| 05/15/2008 | US20080113017 Sterol derivatives, liposomes comprising sterol derivatives and method of loading liposomes with active substances |
| 05/15/2008 | US20080113011 drug mixture comprising interferons, gelatin, phosphatidylcholine didecanoyl, methyl-beta-cyclodextrin, ethylenediamine tetraacetic acid and benzalkonium chloride, having improved pharmacokinetics, used for treating autoimmune and viral diseases, by administering to mucous membranes |
| 05/15/2008 | US20080112994 Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
| 05/15/2008 | US20080112991 Method of enhancing skin absorption of nutrients and active agents |
| 05/15/2008 | US20080112986 Controlled release sterile injectable aripiprazole formulation and method |
| 05/15/2008 | US20080112985 Controlled release sterile injectable aripiprazole formulation and method |
| 05/15/2008 | US20080112984 Novel Hydrogels Based On Polyvinyl Alcohols And Polyvinyl Alcohol Copolymers |
| 05/15/2008 | US20080112972 Preservation of bioactive materials by freeze dried foam |
| 05/15/2008 | US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals |
| 05/15/2008 | US20080112932 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112931 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112919 Tnp-470 polymer conjugates and use thereof |
| 05/15/2008 | US20080112910 Cool feeling composition, cool feeling auxiliary composition, and use thereof |
| 05/15/2008 | US20080112896 Microparticles obtained by spray-freeze-drying a solution or dispersion of a water-soluble matrix such as hyaluronic acid and drug; lightweight, porous to deposit deeply in lungs; mucoadhesion; time-release agents |
| 05/15/2008 | US20080112894 Biocompatible Polymer Compounds For Medicinal Formulations |
| 05/15/2008 | DE112006001853T5 Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten Pharmaceutical compositions containing Clopidogrel bisulfate |
| 05/15/2008 | CA2669009A1 Method for mixing powders |
| 05/15/2008 | CA2668864A1 Pharmaceutical composition comprising a dihydrobenzofuranyl isoindoline and a lipophilic component |
| 05/15/2008 | CA2668733A1 Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| 05/15/2008 | CA2668638A1 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| 05/14/2008 | EP1921094A2 Method for presenting and removing substances |
| 05/14/2008 | EP1921086A1 Antitumor agent |
| 05/14/2008 | EP1920786A1 Oral preparation useful in measuring capacity to metabolize pyridine |
| 05/14/2008 | EP1920785A1 Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| 05/14/2008 | EP1920779A1 Technique for stabilization of yw753 reparation |
| 05/14/2008 | EP1920771A2 Methods of treating hyperlipidemia |
| 05/14/2008 | EP1920766A2 Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| 05/14/2008 | EP1920763A1 Pharmaceutical compositions for inhalation |
| 05/14/2008 | EP1920061A1 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 05/14/2008 | EP1919979A1 Polymer conjugates of k-252a and derivatives thereof |
| 05/14/2008 | EP1919945A1 Mutant of granulocyte-colony stimulating factor(g-csf) and chemically conjugated polypeptide thereof |
| 05/14/2008 | EP1919529A2 Method of removing medical adhesive |
| 05/14/2008 | EP1919509A2 Highly cross-linked reagents for modifying biopharmaceuticals, production and use thereof |
| 05/14/2008 | EP1919508A2 Artificial platelets |
| 05/14/2008 | EP1919507A2 Nanoparticles comprising antibacterial ligands |
| 05/14/2008 | EP1919506A1 Peptide conjugate for oral delivery of hydrophilic peptide analgesics |
| 05/14/2008 | EP1919443A2 Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives |
| 05/14/2008 | EP1687026B1 Method for the treatment of multiple sclerosis by inhibiting il-17 activity |
| 05/14/2008 | EP1651274B1 Bioadhesive gel based on hydroxyethylcellulose |
| 05/14/2008 | EP1572087B1 Antibodies against cancer antigen tmeff2 and uses thereof |
| 05/14/2008 | EP1496875B1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 05/14/2008 | EP1469832B1 Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| 05/14/2008 | EP1455838B1 Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment |
| 05/14/2008 | EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds |
| 05/14/2008 | EP1355636B1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 05/14/2008 | EP1309355B1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 05/14/2008 | EP1274728B1 Methods and compositions for the prevention and treatment of anemia |
| 05/14/2008 | EP1274429B1 Topical formulations for the transdermal delivery of niacin prodrugs and methods of treating hyperlipidemia |
| 05/14/2008 | EP1248600B1 Improved hiv protease inhibitors pharmaceutical formulations |
| 05/14/2008 | EP1171159B1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 05/14/2008 | EP0783313B1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 05/14/2008 | CN201058126Y Locating and unlocking capsule for smectite segmented intestine |
| 05/14/2008 | CN101180400A Nanoparticles comprising rna ligands |
| 05/14/2008 | CN101180319A Aldehyde conjugated flavonoid preparations |
| 05/14/2008 | CN101180081A Stabilized polypeptide formulations |
| 05/14/2008 | CN101180061A Compounds, and compositions containing the compounds, and method for treatment of metastatic melanoma and other cancers |
| 05/14/2008 | CN101180052A Film coated preparation containing dextrose |
| 05/14/2008 | CN101180047A Use of cyclodextrin complexes containing lipoic acid |
| 05/14/2008 | CN101180046A Stable tablet containing droxidopa |
| 05/14/2008 | CN101180035A Composition for treatment of a detached retina and method of production thereof |
| 05/14/2008 | CN101178961A water soluble magnetic nanometer crystal with high dissolvability and method of producing the same |